8624 J . Org. Chem., Vol. 64, No. 23, 1999
Oestreich and Hoppe
precipitate which was then filtered off and washed with Et2O.
The etheral phase was extracted with H2O and brine, dried
over MgSO4, and the solvent was removed under reduced
pressure. The crude product was purified by flash chromatog-
raphy (1:1 Et2O-hexanes) yielding (S)-17 (1.03 g, 85%, er )
Ster eoselective Cycloca r bolith ia tion of 13a . (+)-
[1R,3S,2(1E)]-2-Ben zylid en e-3-(tr ip h en ylm eth oxy)cyclo-
p en tyl 2,2,4,4-Tetr a m eth yl-1,3-oxa zolid in e-3-ca r boxyla te
(cis-19a ). Following the typical procedure for the stereoselec-
tive cyclocarbolithiation of alkynes, (S)-13a (0.100 g, 0.17
mmol) was treated with s-BuLi (0.18 mL, 0.24 mmol, 1.4 equiv,
1.32 M) and 1 (0.060 g, 0.26 mmol, 1.5 equiv) in Et2O (3 mL)
for 18.5 h at -78 °C. The crude product was purified by flash
chromatography (1:9 to 1:3 Et2O-hexanes; TLC, Rf ) 0.48 in
1:1 Et2O-hexanes) affording cis-19a (0.088 g, 88%, dr ) 95:
95:524) as a colorless oil. [R]20 ) +4.2 (c ) 0.42).
D
Gen er a l P r oced u r e for th e Tr ityla tion 27 of 17. r a c-6-
P h en yl-4-(t r ip h en ylm et h oxy)-5-h exyn yl 2,2,4,4-Tet r a -
m eth yl-1,3-oxa zolid in e-3-ca r boxyla te (r a c-13a ). At room
temperature, trityl chloride (0.749 g, 2.69 mmol, 1.1 equiv) and
DMAP (0.012 g, 0.10 mmol, 0.04 equiv) were dissolved in CH2-
Cl2 (15 mL). To this solution Et3N (0.371 g, 3.66 mmol, 1.5
equiv) and rac-17 (0.844 g, 2.44 mmol), dissolved in CH2Cl2 (5
mL), were subsequently added. After being refluxed overnight
the reaction mixture was quenched with H2O (5 mL) at room
temperature. The organic layer was separated, and the aque-
ous phase was extracted twice with Et2O. The combined
organic phases were dried (MgSO4) and concentrated under
reduced pressure. Flash chromatography (1:1 Et2O-hexanes;
TLC, Rf ) 0.48) of the residue gave rac-13a (0.387 g, 54%) as
a colorless liquid. IR (neat, cm-1): 1691 (CdO, s). 1H NMR
(CDCl3, 300 MHz): δ 7.66-7.60 (m, 6H), 7.39-7.23 (m, 12H),
7.20-7.14 (m, 2H), 4.33 (t, J ) 5.5 Hz, 1H), 4.14 (t, J ) 5.8
Hz, 2H), 3.77 (s, 2H), 2.08-1.73 (m, 4H), 1.62/1.58/1.48/1.42
(4s, 12H). 13C NMR (CDCl3, 75.5 MHz): δ 152.8/152.0, 144.4,
131.5, 129.1, 128.0, 127.9, 127.7, 127.1, 123.1, 95.8/94.8, 89.5,
87.8, 85.8, 76.4/76.1, 64.5, 60.5/59.6, 33.7, 26.6/25.4/24.2, 24.7.
MS (EI): m/z 588 [(M + H)+, 2%]. Anal. Calcd for C39H41NO4:
C, 79.70; H, 7.03; N, 2.38. Found: C, 79.54; H, 7.17; N, 2.39.
Typ ica l P r oced u r e for th e Silyla tion of Alk a n ols. r a c-
4-(ter t-Bu tyldiph en ylsilyloxy)-6-ph en yl-5-h exyn yl 2,2,4,4-
Tetr a m eth yl-1,3-oxa zolid in e-3-ca r boxyla te (r a c-13b). To
a solution of DMAP (0.056 g, 0.46 mmol, 0.5 equiv) in CH2Cl2
(10 mL) TBDPSCl (0.304 g, 1.10 mmol, 1.2 equiv), Et3N (0.112
g, 1.10 mmol, 1.2 equiv), and rac-17 (0.318 g, 0.92 mmol),
dissolved in CH2Cl2 (5 mL), were subsequently added at room
temperature. The reaction mixture was stirred under reflux
overnight and hydrolyzed with H2O (1 mL) at room temper-
ature. The organic layer was separated, and the aqueous phase
was extracted with Et2O. The combined organic phases were
dried over MgSO4, and the solvents were evaporated in vacuo.
The residue was purified by flash chromatography (1:9 to 1:3
Et2O-hexanes; TLC, Rf ) 0.61 in 1:1 Et2O-hexanes) to give
rac-13b (0.538 g, 100%) as a colorless liquid. IR (neat, cm-1):
5) as a white solid. Mp ) 165-166 °C. [R]20 ) +11.4 (c )
D
1
0.22). H NMR (CDCl3, 300 MHz): 7.41-7.37 (m, 6H), 7.22-
6.98 (m, 14H), 6.78 (s, 1H), 5.62 (t, J ) 6.9 Hz, 1H), 4.32 (d,
4.7 Hz, 1H), 3.70 (s, 2H), 2.04-1.97 (m, 2H), 1.80-1.70 (m,
1H), 1.65/1.61/1.58/1.51/1.49/1.46/1.44 (7s, 12H), 1.25-1.11 (m,
1H). 13C NMR (CDCl3, 75.5 MHz): δ 152.8/152.0, 145.2, 143.6,
136.9, 132.4, 129.6, 129.3, 128.4, 127.9, 127.8, 127.5, 95.9/95.0,
86.9, 78.1, 76.6/76.2, 74.3, 60.7/59.9, 31.0, 29.5, 27.2/26.7/25.8/
25.5/24.3.
(-)-[1R,3R,2(1E)]-2-Ben zyliden e-3-(tr iph en ylm eth oxy)-
cyclop en t yl 2,2,4,4-Tet r a m et h yl-1,3-oxa zolid in e-3-ca r -
boxyla te (tr a n s-19a ). As described in the typical procedure
for the stereoselective cyclocarbolithiation of alkynes, (R)-13a
(0.046 g, 0.08 mmol) was cyclized with s-BuLi (0.10 mL, 0.11
mmol, 1.4 equiv, 1.30 M) in the presence of 1 (0.028 g, 0.12
mmol, 1.5 equiv) in Et2O (1.5 mL) for 23 h at -78 °C. Flash
chromatography (1:3 Et2O-hexanes) of the crude product
furnished trans-19a (0.046 g, 100%, dr ) 5:95) as a white solid.
1
Mp ) 67-68 °C. [R]20 ) -50.6 (c ) 0.25). H NMR (CDCl3,
D
300 MHz): 7.48-7.44 (m, 6H), 7.32-7.10 (m, 14H), 6.79 (s,
1H), 6.04-6.00 (m, 1H), 4.56 (d, J ) 4.3 Hz, 1H), 3.72 (s, 2H),
2.41-2.33 (m, 1H), 1.74-1.23 (m, 15H). 13C NMR (CDCl3, 150
MHz): δ 152.6/151.9, 144.7, 143.9, 143.8, 136.5, 136.4, 129.5,
129.1, 128.9, 128.0, 127.9, 127.5, 127.3, 127.0, 95.9/94.8, 86.7,
77.5, 76.3/76.0, 74.0/73.9, 60.5/59.7, 30.5, 29.7/29.6, 28.9/26.8/
26.6/25.7/25.5/25.3/24.2.
[1R,3RS,2(1E)]-2-Ben zylid en e-3-(t r ip h en ylm et h oxy)-
cyclop en t yl 2,2,4,4-Tet r a m et h yl-1,3-oxa zolid in e-3-ca r -
boxyla te (cis-/tr a n s-19a ). rac-13a (0.195 g, 0.33 mmol) was
treated with s-BuLi (0.33 mL, 0.43 mmol, 1.3 equiv, 1.32 M)
and 1 (0.101 g, 0.43 mmol, 1.3 equiv) in Et2O (8 mL) for 6.5 h
at -78 °C according to the typical procedure for the stereose-
lective cyclocarbolithiation. The purification of the crude
product by flash chromatography (1:9 to 1:3 Et2O-hexanes)
gave a mixture of cis-/trans-19a (0.157 g, 80%, dr ) 50:50) and
rac-13a (0.038 g, 20%) as a white solid. IR (KBr, cm-1): 1694
1
1697 (CdO, s). H NMR (CDCl3, 300 MHz): δ 7.76-7.66 (m,
4H), 7.40-7.27 (m, 6H), 7.22-7.12 (m, 5H), 4.62-4.59 (m, 1H),
4.08 (bs, 2H), 3.67 (s, 2H), 1.86 (bs, 4H), 1.52/1.47/1.38/1.31
(4s, 12H), 1.07 (s, 9H). 13C NMR (CDCl3, 75.5 MHz): δ 152.8/
152.0, 136.0, 135.4, 133.6, 131.5, 129.6, 128.1, 127.6, 122.9,
95.8/94.8, 90.2, 85.2, 76.4/76.2, 64.4, 64.0, 60.5/59.6, 35.4, 27.0,
26.6/25.3/24.2, 24.6, 19.3. MS (EI): m/z 583 [M+, 1%]. Anal.
Calcd for C36H45NO4Si: C, 74.06; H, 7.77; N, 2.40. Found: C,
74.37; H, 7.93; N, 2.30.
(CdO, s). MS (EI): m/z 587 [M+, 6%]. Anal. Calcd for C39H41
-
NO4: C, 79.70; H, 7.03; N, 2.38. Found: C, 79.58; H, 7.12; N,
2.58.
Ster eoselective Cycloca r bolith ia tion of 13b. (+)-
[1R,3S,2(1E)]-2-Ben zylid en e-3-(ter t-b u t yld ip h en ylsilyl-
oxy)cyclop en tyl 2,2,4,4-Tetr a m eth yl-1,3-oxa zolid in e-3-
ca r boxyla te (cis-19b). In analogy to the typical procedure
for the stereoselective cyclocarbolithiation, (S)-13b (0.500 g,
0.86 mmol) was cyclized with s-BuLi (0.92 mL, 1.20 mmol, 1.4
equiv, 1.30 M) and 1 (0.301 g, 1.28 mmol, 1.5 equiv) in Et2O
(15 mL) for 20 h at -78 °C. The crude product was purified
by flash chromatography (1:9 Et2O-hexanes; TLC, Rf ) 0.57
in 1:1 Et2O-hexanes) to give cis-19b (0.410 g, 82%, dr ) 95:
(-)-[1R,3S,2(1E)]-2-Ben zyliden e-3-(N,N-diben zylam in o)-
cyclop en t yl 2,2,4,4-Tet r a m et h yl-1,3-oxa zolid in e-3-ca r -
boxyla te (cis-18). According to the typical procedure for the
stereoselective cyclocarbolithiation of alkynes, (S)-12 (0.110 g,
0.21 mmol) was cyclized with s-BuLi (0.25 mL, 0.31 mmol, 1.5
equiv, 1.25 M) in the presence of 1 (0.074 g, 0.31 mmol, 1.5
equiv) in Et2O (3 mL) for 20 h at -78 °C. The crude product
was purified by flash chromatography (3:7 Et2O-hexanes;
TLC, Rf ) 0.65 in 1:1 Et2O-hexanes) to yield cis-18 (0.077 g,
5) as a colorless, highly viscous oil. [R]20 ) +34.5 (c ) 0.31).
D
1H NMR (CDCl3, 300 MHz): δ 7.71-7.64 (m, 4H, Ph), 7.41-
7.22 (m, 8H), 7.12-7.00 (m, 3H), 6.76 (s, 1H), 5.64 (t, J ) 6.8
Hz, 1H), 4.82 (d, J ) 4.1 Hz, 1H), 3.72 (s, 2H), 2.24-1.90 (m,
4H), 1.60/1.59 (2bs, 6H), 1.45/1.44 (2bs, 6H), 1.03 (s, 9H). 13C
NMR (CDCl3, 75.5 MHz): δ 153.0/152.2, 144.1, 136.5, 135.9,
134.8, 134.4, 133.8, 131.3, 129.6, 129.5, 128.9, 128.0, 127.5,
127.3, 95.8/95.1, 77.3, 76.6/76.1, 72.7, 60.6/59.9, 34.2, 29.3,
27.0, 26.7/25.8/25.4/24.3, 19.3.
70%) with traces of (S)-12 as a colorless oil. [R]20 ) -76.6 (c
D
) 0.15). IR (neat, cm-1): 1697 (CdO, s). 1H NMR (CDCl3, 600
MHz): δ 7.40-7.16 (m, 12H), 7.04-7.02 (m, 3H), 6.92 (m, 1H),
5.56 (m, 1H), 4.20 (m, 1H), 3.85 (ψ-t, J ) 12.6 Hz, 2H), 3.70
(2s, 2H), 3.24 (2d, J ) 12.6 Hz, 2H), 2.28-2.18 (m, 1H), 2.04-
1.96 (m, 2H), 1.85-1.78 (m, 1H), 1.60/1.56/1.49/1.45/1.42/1.39/
1.33 (7s, 12H). 13C NMR (CDCl3, 150 MHz): δ 152.6/151.9,
141.8, 141.7, 139.2, 136.0, 135.9, 130.3, 129.3, 128.7, 128.3,
127.9, 127.6, 127.1, 126.8, 96.0/94.6, 80.3, 76.4/76.0, 60.4, 60.8/
59.5, 54.9/54.8, 30.4/30.3, 22.1, 26.7/26.6/25.5/25.4/25.3/25.2/
24.2/24.1. MS (EI): m/z 524 [M+, 1%]. Anal. Calcd for
(-)-[1R,3RS,2(1E)]-2-Ben zylid en e-3-(ter t-b u t yld ip h e-
n ylsilyloxy)cyclop en tyl 2,2,4,4-Tetr a m eth yl-1,3-oxa zoli-
d in e-3-ca r boxyla te (cis-/tr a n s-19b). Following the typical
procedure for the stereoselective cyclocarbolithiation, rac-13b
(0.100 g, 0.17 mmol) was allowed to react with s-BuLi (0.18
mL, 0.24 mmol, 1.4 equiv, 1.30 M) and 1 (0.060 g, 0.26 mmol,
1.5 equiv) in Et2O (3 mL) for 23.5 h at -78 °C. Flash
C
34H40N2O3: C, 77.83; H, 7.68; N, 5.34. Found: C, 77.56; H,
7.67; N, 5.41.